|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
|
AR095196A1
(es)
|
2013-03-15 |
2015-09-30 |
Regeneron Pharma |
Medio de cultivo celular libre de suero
|
|
SI4374873T1
(sl)
|
2013-07-12 |
2026-01-30 |
Astellas Us Llc |
Sredstvo za uporabo pri zdravljenju ali preprečevanju oftalmoloških stanj
|
|
US9914769B2
(en)
|
2014-07-15 |
2018-03-13 |
Kymab Limited |
Precision medicine for cholesterol treatment
|
|
DE202014010499U1
(de)
|
2013-12-17 |
2015-10-20 |
Kymab Limited |
Targeting von humaner PCSK9 zur Cholesterinbehandlung
|
|
GB201403775D0
(en)
|
2014-03-04 |
2014-04-16 |
Kymab Ltd |
Antibodies, uses & methods
|
|
CA2943242A1
(en)
*
|
2014-03-21 |
2015-09-24 |
X-Body, Inc. |
Bi-specific antigen-binding polypeptides
|
|
WO2015200905A2
(en)
|
2014-06-28 |
2015-12-30 |
Oligasis, Llc |
Dual pdgf/vegf antagonists
|
|
EP3218400A1
(en)
*
|
2014-11-10 |
2017-09-20 |
F. Hoffmann-La Roche AG |
Anti-pdgf-b antibodies and methods of use
|
|
JP2017537896A
(ja)
|
2014-11-10 |
2017-12-21 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
二重特異性抗体及び眼科に使用する方法
|
|
WO2016075035A1
(en)
|
2014-11-10 |
2016-05-19 |
F. Hoffmann-La Roche Ag |
Anti-ang2 antibodies and methods of use
|
|
SG11201702550WA
(en)
|
2014-11-10 |
2017-04-27 |
Hoffmann La Roche |
ANTI-IL-1beta ANTIBODIES AND METHODS OF USE
|
|
US20160144025A1
(en)
*
|
2014-11-25 |
2016-05-26 |
Regeneron Pharmaceuticals, Inc. |
Methods and formulations for treating vascular eye diseases
|
|
JP2018506280A
(ja)
*
|
2015-02-06 |
2018-03-08 |
カドモン コーポレイション，リミティド ライアビリティ カンパニー |
免疫調節薬
|
|
US9139653B1
(en)
|
2015-04-30 |
2015-09-22 |
Kymab Limited |
Anti-human OX40L antibodies and methods of treatment
|
|
EP3278810A4
(en)
|
2015-03-31 |
2018-11-21 |
Ildong Pharm Co., Ltd. |
Pharmaceutical composition for preventing and treating eye diseases, containing, as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused
|
|
RU2749674C2
(ru)
|
2015-07-29 |
2021-06-16 |
Аллерган, Инк. |
Антитела против ang-2, содержащие только тяжелую цепь
|
|
TW202440903A
(zh)
|
2015-08-04 |
2024-10-16 |
美商再生元醫藥公司 |
補充牛磺酸之細胞培養基及用法（一）
|
|
MY200764A
(en)
|
2015-12-16 |
2024-01-14 |
Regeneron Pharma |
Compositions and methods of manufacturing protein microparticles
|
|
IL290457B2
(en)
|
2015-12-30 |
2025-02-01 |
Kodiak Sciences Inc |
Antibodies and their conjugates
|
|
KR102379464B1
(ko)
|
2016-06-20 |
2022-03-29 |
키맵 리미티드 |
항-pd-l1 항체
|
|
US11352420B2
(en)
*
|
2016-07-01 |
2022-06-07 |
Paracrine Therapeutics Ab |
Methods and compositions for PDGF-CC inhibition
|
|
AU2017312785B2
(en)
|
2016-08-16 |
2024-10-10 |
Regeneron Pharmaceuticals, Inc. |
Methods for quantitating individual antibodies from a mixture
|
|
WO2018039499A1
(en)
|
2016-08-24 |
2018-03-01 |
Regeneron Pharmaceuticals, Inc. |
Host cell protein modification
|
|
WO2018083248A1
(en)
|
2016-11-03 |
2018-05-11 |
Kymab Limited |
Antibodies, combinations comprising antibodies, biomarkers, uses & methods
|
|
CN109021104B
(zh)
*
|
2017-06-12 |
2022-08-12 |
上海睿智化学研究有限公司 |
一种抗人血小板衍生生长因子β受体的抗体及其应用
|
|
KR20210084695A
(ko)
|
2017-07-06 |
2021-07-07 |
리제너론 파마슈티칼스 인코포레이티드 |
당단백질을 만들기 위한 세포 배양 과정
|
|
US20190194298A1
(en)
|
2017-12-22 |
2019-06-27 |
Regeneron Pharmaceuticals, Inc. |
System and method for characterizing drug product impurities
|
|
CA3085177A1
(en)
|
2018-01-31 |
2019-08-08 |
Regeneron Pharamaceuticals, Inc. |
System and method for characterizing size and charge variant drug product impurities
|
|
TW202311746A
(zh)
|
2018-02-02 |
2023-03-16 |
美商再生元醫藥公司 |
用於表徵蛋白質二聚合之系統及方法
|
|
AU2019227531B2
(en)
|
2018-02-28 |
2025-01-30 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods for identifying viral contaminants
|
|
CA3092588A1
(en)
|
2018-03-02 |
2019-09-06 |
Kodiak Sciences Inc. |
Il-6 antibodies and fusion constructs and conjugates thereof
|
|
US12253490B2
(en)
|
2018-03-19 |
2025-03-18 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
US11054389B2
(en)
|
2018-03-19 |
2021-07-06 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
US12259355B2
(en)
|
2018-03-19 |
2025-03-25 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
GB201806918D0
(en)
*
|
2018-04-27 |
2018-06-13 |
Enleofen Bio Pte Ltd |
Combination treatment for eye fibrosis
|
|
CN108586611B
(zh)
*
|
2018-04-28 |
2021-01-26 |
暨南大学 |
重组全人源抗破伤风毒素单克隆抗体
|
|
TW202016125A
(zh)
|
2018-05-10 |
2020-05-01 |
美商再生元醫藥公司 |
用於定量及調節蛋白質黏度之系統與方法
|
|
MY204234A
(en)
|
2018-08-27 |
2024-08-16 |
Regeneron Pharma |
Use of raman spectroscopy in downstream purification
|
|
WO2020047067A1
(en)
|
2018-08-30 |
2020-03-05 |
Regeneron Pharmaceuticals, Inc. |
Methods for characterizing protein complexes
|
|
US12098206B2
(en)
|
2018-10-05 |
2024-09-24 |
Seoul National University R&Db Foundation |
PDGF receptor antibody and use thereof
|
|
JP2022517720A
(ja)
|
2019-01-16 |
2022-03-10 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ジスルフィド結合を特徴付けるための方法
|
|
EP4378485A3
(en)
*
|
2019-03-08 |
2024-08-28 |
LinXis B.V. |
Internalizing binding molecules targeting receptors involved in cell proliferation or cell differentiation
|
|
KR20220050087A
(ko)
|
2019-05-03 |
2022-04-22 |
싱가포르 헬스 서비시즈 피티이 엘티디 |
대사성 질환의 치료 및 예방
|
|
JP7541534B2
(ja)
|
2019-05-13 |
2024-08-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
改善された競合的リガンド結合アッセイ
|
|
PE20240329A1
(es)
|
2019-06-05 |
2024-02-27 |
Regeneron Pharma |
Dispositivos y metodos para administracion de dosis de precision
|
|
KR20260058863A
(ko)
|
2019-09-24 |
2026-04-29 |
리제너론 파아마슈티컬스, 인크. |
크로마토그래피의 사용 및 재생을 위한 시스템 및 방법
|
|
CA3157509A1
(en)
|
2019-10-10 |
2021-04-15 |
Kodiak Sciences Inc. |
Methods of treating an eye disorder
|
|
US12297451B1
(en)
|
2019-10-25 |
2025-05-13 |
Regeneron Pharmaceuticals, Inc. |
Cell culture medium
|
|
US11730793B2
(en)
|
2019-11-25 |
2023-08-22 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous emulsions
|
|
CN115052663B
(zh)
|
2020-01-08 |
2026-06-09 |
辛瑟斯治疗股份有限公司 |
Alk5抑制剂缀合物及其用途
|
|
CA3165060C
(en)
|
2020-01-21 |
2023-06-20 |
Yiming Zhao |
Deglycosylation methods for electrophoresis of glycosylated proteins
|
|
CA3170712A1
(en)
*
|
2020-02-07 |
2021-08-12 |
Biorion Technologies B.V. |
Platelet derived growth factor receptor (pdgfr) antibodies, conjugates, compositions, and uses thereof.
|
|
KR20230058094A
(ko)
|
2020-08-31 |
2023-05-02 |
리제너론 파아마슈티컬스, 인크. |
세포 배양 성능을 개선하고 아스파라긴 서열 변이체를 완화하기 위한 아스파라긴 공급 전략
|
|
JP2023541934A
(ja)
*
|
2020-09-16 |
2023-10-04 |
リンクシス ベスローテン フェンノートシャップ |
内在化結合分子
|
|
EP4251128A1
(en)
|
2020-11-25 |
2023-10-04 |
Regeneron Pharmaceuticals, Inc. |
Sustained release formulations using non-aqueous membrane emulsification
|
|
IL303675A
(en)
|
2020-12-17 |
2023-08-01 |
Regeneron Pharma |
Production of protein thermal microgels
|
|
MX2023008527A
(es)
|
2021-01-20 |
2023-07-28 |
Regeneron Pharma |
Metodos para mejorar el valor proteico en cultivo celular.
|
|
JP7894873B2
(ja)
*
|
2021-01-25 |
2026-07-24 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
抗ｐｄｇｆ－ｂ抗体及び肺動脈高血圧症（ｐａｈ）を治療するための使用方法
|
|
TW202246325A
(zh)
|
2021-03-03 |
2022-12-01 |
美商再生元醫藥公司 |
用於定量及修飾蛋白質黏度之系統及方法
|
|
EP4315344A1
(en)
|
2021-03-26 |
2024-02-07 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for developing mixing protocols
|
|
AU2022286340A1
(en)
|
2021-06-01 |
2024-01-04 |
Regeneron Pharmaceuticals, Inc. |
Microchip capillary electrophoresis assays and reagents
|
|
CN119039440A
(zh)
*
|
2021-07-02 |
2024-11-29 |
来凯医药科技(上海)有限公司 |
活化的肝星状细胞（hsc）的消耗及其用途
|
|
MX2024001877A
(es)
|
2021-08-10 |
2024-02-28 |
Kymab Ltd |
Tratamiento de dermatitis atopica.
|
|
AR127006A1
(es)
|
2021-09-08 |
2023-12-06 |
Regeneron Pharma |
UN MÉTODO BASADO EN ESPECTROMETRÍA DE MASAS Y DE ALTO RENDIMIENTO PARA CUANTIFICAR ANTICUERPOS Y OTRAS PROTEÍNAS QUE CONTIENEN Fc
|
|
US12649031B2
(en)
|
2021-09-08 |
2026-06-09 |
Regeneron Pharmaceuticals, Inc. |
Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation
|
|
AU2022348521A1
(en)
|
2021-09-20 |
2024-04-04 |
Regeneron Pharmaceuticals, Inc. |
Methods of controlling antibody heterogeneity
|
|
EP4413364A2
(en)
|
2021-10-07 |
2024-08-14 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods of ph modeling and control
|
|
EP4413359A1
(en)
|
2021-10-07 |
2024-08-14 |
Regeneron Pharmaceuticals, Inc. |
Ph meter calibration and correction
|
|
WO2023076340A1
(en)
|
2021-10-26 |
2023-05-04 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods for generating laboratory water and distributing laboratory water at different temperatures
|
|
EP4493921A1
(en)
|
2022-03-18 |
2025-01-22 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for analyzing polypeptide variants
|
|
US11723955B1
(en)
|
2022-05-13 |
2023-08-15 |
Allgenesis Biotherapeutics Inc. |
VEGFR fusion protein pharmaceutical composition
|
|
USD1120314S1
(en)
|
2022-11-30 |
2026-03-24 |
Regeneron Pharmaceuticals, Inc. |
Dose delivery device
|
|
EP4634659A1
(en)
|
2022-12-16 |
2025-10-22 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for assessing chromatographic column integrity
|
|
US20240245779A1
(en)
|
2023-01-25 |
2024-07-25 |
Regeneron Pharmaceuticals, Inc. |
Methods of modeling liquid protein composition stability
|
|
US20240248097A1
(en)
|
2023-01-25 |
2024-07-25 |
Regeneron Pharmaceuticals, Inc. |
Mass spectrometry-based characterization of antibodies co-expressed in vivo
|
|
TW202445138A
(zh)
|
2023-02-01 |
2024-11-16 |
美商再生元醫藥公司 |
用於生物巨分子分析之具質譜法的不對稱流場流分離
|
|
EP4669963A2
(en)
|
2023-02-22 |
2025-12-31 |
Regeneron Pharmaceuticals, Inc. |
SYSTEM FITNESS PARAMETERS AND COLUMN AGING
|
|
JP2026514305A
(ja)
|
2023-05-01 |
2026-05-08 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
フェノールまたはベンジルアルコールを使用した複数回投与抗体医薬品
|
|
US20250086164A1
(en)
|
2023-09-08 |
2025-03-13 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for assessing chromatographic column integrity
|
|
EP4780828A2
(en)
|
2023-09-18 |
2026-07-29 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for developing chromatography protocols
|
|
US20250109905A1
(en)
|
2023-09-29 |
2025-04-03 |
Regeneron Pharmaceuticals, Inc. |
Lyophilization using controlled nucleation
|
|
CN122138969A
(zh)
|
2023-10-18 |
2026-06-02 |
瑞泽恩制药公司 |
从过程中上游细胞培养物材料中快速纯化单克隆抗体
|
|
AU2024373307A1
(en)
|
2023-11-02 |
2026-05-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for reducing lipase activity using stress
|
|
WO2025166281A1
(en)
|
2024-02-01 |
2025-08-07 |
Regeneron Pharmaceuticals, Inc. |
Platform for charge-detection mass spectrometry analysis of aavs
|
|
TW202600593A
(zh)
|
2024-02-16 |
2026-01-01 |
美商再生元醫藥公司 |
製造濃縮配製包括蛋白質之藥品物質之方法，以及該方法製造之濃縮配製之藥品物質
|
|
TW202602489A
(zh)
|
2024-03-15 |
2026-01-16 |
美商再生元醫藥公司 |
作為經穩定的蛋白質調配物之賦形劑的聚山梨醇酯及聚氧乙烯山梨糖醇酐
|
|
CN118440214B
(zh)
*
|
2024-04-02 |
2025-01-28 |
山东大学 |
一种靶向PDGFRβ的嵌合抗原受体、CAR-T细胞及应用
|
|
WO2025259840A1
(en)
|
2024-06-13 |
2025-12-18 |
Regeneron Pharmaceuticals, Inc. |
Methods and systems for scaled chromatography
|
|
CN118638237B
(zh)
*
|
2024-07-16 |
2025-02-28 |
山东大学 |
一种靶向人PDGFRβ的单链抗体及其在CAR-T免疫治疗中的应用
|
|
WO2026025028A1
(en)
|
2024-07-26 |
2026-01-29 |
Regeneron Pharmaceuticals, Inc. |
Methods of making ultra-high concentrated protein formulations using lyophilization
|
|
WO2026060350A1
(en)
|
2024-09-13 |
2026-03-19 |
Regeneron Pharmaceuticals, Inc. |
Methods of improving photo stability and controlling formation of hmw species in biologic formulations, and biologic formulations produced by the methods
|
|
WO2026076201A2
(en)
|
2024-10-03 |
2026-04-09 |
Regeneron Pharmaceuticals, Inc. |
Systems and methods for producing therapeutic proteins using single pass tangential flow filtration for in-line concentration and volume reduction of production pools
|
|
WO2026080597A1
(en)
|
2024-10-08 |
2026-04-16 |
Regeneron Pharmaceuticals, Inc. |
Sustained delivery of biologics and non-aqueous manufacture of same
|
|
WO2026112457A2
(en)
|
2024-11-21 |
2026-05-28 |
Regeneron Pharmaceuticals, Inc. |
Heterodimeric antigen-binding molecules that bind to viral particles and uses thereof
|
|
WO2026136650A1
(en)
|
2024-12-20 |
2026-06-25 |
Regeneron Pharmaceuticals, Inc. |
Fixed seed train schedule for improved protein production
|